Group comparison - Phase 2

cBioPortal / icebox

very low priority issues

0 stars 0 forks source link

Group comparison - Phase 2 #219

Open jjgao opened 5 years ago

jjgao commented 5 years ago

[x] Methylation tab cBioPortal/cbioportal#7683
[ ] Should we support continuous CNA data?
[x] Support patient level enrichments analysis cBioPortal/cbioportal#4637
[x] treat overlapping part as a separate group cBioPortal/cbioportal#5803
[x] Integrate the Comparison component with Results page cBioPortal/cbioportal#5802
[x] Comparison tab in Results: allow group samples by gene/track cBioPortal/cbioportal#5804
[ ] Enrichments test for oncogenic mutations/cnas/fusions only
[ ] Enrichments test for pathways
[x] Enrichments test for mutational signatures

stale[bot] commented 4 years ago

This issue has been automatically marked as stale because it has not had recent activity. It will be closed if no further activity occurs. Thank you for your contributions.

stale[bot] commented 4 years ago

This issue has been automatically marked as stale because it has not had recent activity. It will be closed if no further activity occurs. Thank you for your contributions.

stale[bot] commented 4 years ago

This issue has been automatically marked as stale because it has not had recent activity. It will be closed if no further activity occurs. Thank you for your contributions.

stale[bot] commented 3 years ago

This issue has been automatically marked as stale because it has not had recent activity. It will be closed if no further activity occurs. Thank you for your contributions.

stale[bot] commented 3 years ago

This issue has been automatically marked as stale because it has not had recent activity. It will be closed if no further activity occurs. Thank you for your contributions.

stale[bot] commented 3 years ago

This issue has been automatically marked as stale because it has not had recent activity. It will be closed if no further activity occurs. Thank you for your contributions.

stale[bot] commented 3 years ago

This issue has been automatically marked as stale because it has not had recent activity. It will be closed if no further activity occurs. Thank you for your contributions.